Physician profile
Scott A Cooper
NPI 1427335348
$15,037.10
in general payments reported to CMS, 2019-2025
11 companies · $8,212 in 2025
The $8,212 reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.00 · 2023: $338 · 2024: $6,456 · 2025: $8,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,398 · Food and Beverage: $3,217 · Travel and Lodging: $2,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,397.75 |
| Food and Beverage | $3,216.82 |
| Travel and Lodging | $2,392.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14,404.47 | 2022-2025 | |
| Revance Therapeutics, INC. | $170.13 | 2024-2025 | Daxxify |
| Smith+Nephew, INC. | $161.38 | 2023-2025 | Grafix, Collagenase Santyl, Oasis |
| Organogenesis INC. | $78.22 | 2024-2025 | Nushield, Via Matrix |
| Abbvie INC. | $53.14 | 2024-2025 | |
| Hartmann USA, INC. | $48.09 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Reprise Biomedical, INC. | $39.88 | 2024 | Miro3d |
| Paratek Pharmaceuticals, INC. | $30.28 | 2024 | Nuzyra |
| Kerecis Limited | $20.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $17.72 | 2024 | |
| Integra Lifesciences Corporation | $13.57 | 2024 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.